Cadence Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.27M Buy
178,573
+5,457
+3% +$253K 0.54% 40
2025
Q1
$10.6M Buy
173,116
+3,558
+2% +$217K 0.75% 27
2024
Q4
$9.59M Sell
169,558
-2,241
-1% -$127K 0.65% 31
2024
Q3
$8.89M Buy
171,799
+2,681
+2% +$139K 0.61% 36
2024
Q2
$7.02M Buy
169,118
+3,959
+2% +$164K 0.53% 41
2024
Q1
$8.96M Buy
165,159
+290
+0.2% +$15.7K 0.65% 35
2023
Q4
$8.46M Buy
164,869
+45,053
+38% +$2.31M 0.69% 33
2023
Q3
$6.95M Buy
119,816
+1,234
+1% +$71.6K 0.61% 37
2023
Q2
$7.58M Buy
118,582
+910
+0.8% +$58.2K 0.66% 34
2023
Q1
$8.16M Buy
117,672
+647
+0.6% +$44.8K 0.75% 28
2022
Q4
$8.42M Buy
117,025
+1,978
+2% +$142K 0.78% 28
2022
Q3
$8.18M Buy
115,047
+8,538
+8% +$607K 0.85% 25
2022
Q2
$8.2M Sell
106,509
-2,316
-2% -$178K 1.18% 23
2022
Q1
$7.95M Buy
108,825
+601
+0.6% +$43.9K 0.99% 29
2021
Q4
$6.75M Buy
108,224
+2,943
+3% +$184K 0.84% 33
2021
Q3
$6.23M Buy
105,281
+2,841
+3% +$168K 0.87% 35
2021
Q2
$6.85M Sell
102,440
-7,423
-7% -$496K 0.99% 28
2021
Q1
$6.94M Buy
109,863
+3,015
+3% +$190K 1.05% 26
2020
Q4
$6.63M Buy
106,848
+10,684
+11% +$663K 1.04% 25
2020
Q3
$5.8M Buy
96,164
+5,074
+6% +$306K 1.14% 22
2020
Q2
$5.36M Buy
91,090
+34
+0% +$2K 1.11% 22
2020
Q1
$5.08M Buy
91,056
+2,177
+2% +$121K 1.28% 19
2019
Q4
$5.71M Buy
88,879
+215
+0.2% +$13.8K 1.05% 21
2019
Q3
$4.5M Buy
88,664
+2,476
+3% +$126K 0.42% 38
2019
Q2
$3.91M Buy
86,188
+31,200
+57% +$1.42M 0.38% 47
2019
Q1
$2.62M Buy
54,988
+48
+0.1% +$2.29K 0.26% 61
2018
Q4
$2.86M Buy
54,940
+48,863
+804% +$2.54M 0.34% 54
2018
Q3
$377K Sell
6,077
-953
-14% -$59.1K 0.04% 180
2018
Q2
$389K Hold
7,030
0.04% 176
2018
Q1
$445K Sell
7,030
-112
-2% -$7.09K 0.04% 155
2017
Q4
$438K Buy
+7,142
New +$438K 0.04% 164